Moore S, Kondo M, Copeland M, Meienhofer J
J Med Chem. 1975 Nov;18(11):1098-101. doi: 10.1021/jm00245a010.
2-Deamino- and N2-(gamma-hydroxypropyl)actinomycin D were synthesized by modification of the parent actinomycin D molecule at the 2 position of the phenoxazinone moiety. The common intermediate was 2-deamino-2-chloroactinomycin D. Catalytic hydrogenation of this material afforded the 2-deamino derivative while treatment with gamma-hydroxypropylamine yielded the N2-(gamma-hydroxypropyl) derivative. These 2-substituted actinomycin D derivatives were less potent in microbiological assays than the parent compound. Evaluation of activity in vivo against three murine tumor systems indicated that optimal dose levels of 2-deaminoactinomydin D were 50 times greater than toxic dose levels of actinomycin D. N2-(gamma-hydroxyporpyl)actinomycin D exhibited antitumor activity similar to the parent compound.
通过在吩恶嗪酮部分的2位修饰母体放线菌素D分子,合成了2-脱氨基-和N2-(γ-羟丙基)放线菌素D。共同中间体是2-脱氨基-2-氯放线菌素D。该物质的催化氢化得到2-脱氨基衍生物,而用γ-羟丙胺处理则产生N2-(γ-羟丙基)衍生物。这些2-取代的放线菌素D衍生物在微生物学试验中的效力低于母体化合物。对三种小鼠肿瘤系统的体内活性评估表明,2-脱氨基放线菌素D的最佳剂量水平比放线菌素D的毒性剂量水平高50倍。N2-(γ-羟丙基)放线菌素D表现出与母体化合物相似的抗肿瘤活性。